E-LIB Suche - Ergebnisse für: Juergens, R.A.

1

44O Updated results from a phase I study evaluating the KRA..:

Rojas, C.I. ; Lugowska, I. ; Juergens, R....
ESMO Open. 9 (2024) - p. 102273 , 2024

Link: https://doi.org/10.1016/..

2

MA10.06 CARMA-BROS: CAncers with Rare Molecular Alterations..:

Al Agha, F. ; Raptis, S. ; Zhan, L.J....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S134-S135 , 2023

Link: https://doi.org/10.1016/..

3

EP04.02-004 The Patient Impact of Liquid Biopsy - Health-Re..:

Corke, L. ; Laskin, J. ; Agulnik, J....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S261-S262 , 2022

Link: https://doi.org/10.1016/..

4

EP08.02-034 OCELOT - Osimertinib then Chemotherapy in EGFR+..:

Breadner, D. ; Liu, G. ; Rothenstein, J....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S412-S413 , 2022

Link: https://doi.org/10.1016/..

5

Does Tumor Response Correlate With Quality of Life Changes ..:

Wong, R.K. ; Lajkosz, K. ; Myrehaug, S.D....
International Journal of Radiation Oncology*Biology*Physics. 111 (2021) 3 - p. e81-e82 , 2021

Link: https://doi.org/10.1016/..

6

Impact of Stereotactic Body Radiotherapy (SBRT) in Oligopro..:

Ramadan, S. ; Quan, K. ; Schnarr, K.L....
International Journal of Radiation Oncology*Biology*Physics. 111 (2021) 3 - p. e479 , 2021

Link: https://doi.org/10.1016/..

7

Optimizing the SPECT Imaging Workflow For Individualized Do..:

Driscoll, B. ; Wong, R. ; Vishway, C....
International Journal of Radiation Oncology*Biology*Physics. 108 (2020) 3 - p. e588-e589 , 2020

Link: https://doi.org/10.1016/..

8

A Canadian cancer trials group phase IB study of durvalumab..:

Nehra, J. ; Bradbury, P. A. ; Ellis, P. M....
Investigational New Drugs. 38 (2020) 5 - p. 1442-1447 , 2020

Link: https://doi.org/10.1007/..

9

Immuno-Oncology—The New Paradigm of Lung Cancer Treatment:

Dawe, D.E. ; Harlos, C.H. ; Juergens, R.A.
Current Oncology. 27 (2020) 12 - p. 78-86 , 2020

Link: https://doi.org/10.3747/..

10

Canadian Consensus: A New Systemic Treatment Algorithm for ..:

Melosky, B. ; Banerji, S. ; Blais, N....
Current Oncology. 27 (2020) 2 - p. 146-155 , 2020

Link: https://doi.org/10.3747/..

11

Resource Use in the Last Three Months of Life by Lung Cance..:

Wang, Y. ; Van Dam, A. ; Slaven, M....
Current Oncology. 26 (2019) 4 - p. 247-252 , 2019

Link: https://doi.org/10.3747/..

12

Canadian Consensus: Oligoprogressive, Pseudoprogressive, an..:

Laurie, S.A. ; Banerji, S. ; Blais, N....
Current Oncology. 26 (2019) 1 - p. 81-93 , 2019

Link: https://doi.org/10.3747/..

13

Quantifying Renal And Tumor Doses with Individualized Dosim..:

Wong, R. ; Laidley, D. ; Myrehaug, S.D....
International Journal of Radiation Oncology*Biology*Physics. 105 (2019) 1 - p. S205 , 2019

Link: https://doi.org/10.1016/..

14

Breaking the biomarker code: PD-L1 expression and checkpoin..:

Melosky, B. ; Chu, Q. ; Juergens, R.A....
Cancer Treatment Reviews. 65 (2018) - p. 65-77 , 2018

Link: https://doi.org/10.1016/..

15

Real-World Benefit of Nivolumab in A Canadian Non-Small-Cel..:

Juergens, R.A. ; Mariano, C. ; Jolivet, J....
Current Oncology. 25 (2018) 6 - p. 384-392 , 2018

Link: https://doi.org/10.3747/..